ACADIA Pharmaceuticals Inc.

Q4 2025 13F Holders

Symbol
ACAD
CUSIP
004225108
Type
Equity
Class
COM
Num filings
349
Total reported value, excl. options
$3.89 B
Manager Report Date Value ($000) Shares Option Type